spirapril
This page covers all spirapril drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Angiotensin-converting enzyme.
Targets
Marketed (1)
- Renormax · Cardiovascular
Patent intelligence
- spirapril patent landscape — aggregated cliff calendar, attackable patents, originator estates